Colestyramine(Albireo)

N/A

Report date: 2026/03/13 20:02:36

Base Information

Drug NameColestyramine(Albireo)
Drug Alias Name考来烯胺（Albireo）A-3384
ClassificationSmall molecules
Mechanisms of ActionBile acid binding protein modulators
TargetsBile acid binding protein
Therapy Area/IndicationsProgressive familial intrahepatic cholestasisLiver DiseasesLiver Cirrhosis, Biliary +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlbireo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlbireo Pharma Inc
Active IndicationsN/A
Inactive IndicationsProgressive familial intrahepatic cholestasisLiver DiseasesLiver Cirrhosis, Biliary +[5] 

Other Information

ATC CodeN/A
Related LinksN/A